ImClone Investigational Site

Ann Arbor, Michigan 48109

0 studies enrolling now · 7 studies all time

What they study most

Cancer, Colorectal Cancer, Colorectal Neoplasms, Hepatocellular Carcinoma, Malignant Solid Tumor, Metastases, Neoplasm, Prostate Cancer, Solid Tumor

Studies at this site

• A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors — Completed
• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed
• Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes — Completed
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer — Completed
• A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed